tirzepatide and colonoscopy Had to STOP my GLP1 | Experience #tirzepatide #weightloss # colonoscopy Colonoscopy Prep and GLP-1 Agonists:

Maintaining WL is inherently difficult because of counter-regulatory neuroendocrine pathways that promote weight regain by influencing hunger and sati- ety, which are a component of appetite, and potentially by decreasing energy expenditure (14,15)

"If you start the medication, you need to anticipate that you need to stay on it

Body Composition and Metabolic Parameters Research on component peptides revealed favorable effects on body composition and metabolic markers[10]: Significant reductions in waist circumference (10-15 cm reductions observed) Preferential visceral fat loss documented through imaging studies Preserved lean body mass relative to total weight loss in most studies Improved body composition ratios with fat mass reductions exceeding total weight loss percentages Type 2 Diabetes Research Glycemic Control Studies Investigations in type 2 diabetes models demonstrated robust glucose-lowering effects[11]: HbA1c reductions of 2.0-2.4% observed with GLP3 in phase 2 diabetes trials Fasting plasma glucose reductions of 40-60 mg/dL documented across dose ranges Improved continuous glucose monitoring parameters including time in range and glucose variability CagriSema combination achieved superior glycemic control compared to individual components Studies showed that 72% of participants with prediabetes reverted to normoglycemia with GLP3 treatment, suggesting potential diabetes prevention applications[12]

The question is what happens when you stop these medications

In addition, it is yet unknown how the physical and chemical features of SGLT-2is regulate their transportation in the CNS

Eur J Nutr